Iconovo establishes Nordic pharmaceutical sales

Why are inhalation devices so difficult to develop?

World COPD Day November 17

Iconovo reports Q3 and arranges pandemic event

Delårsrapport januari-september 2022

Iconovo was founded to transform inhaled therapy

The idea for Iconovo arose when Orest Lastow saw a clear need to change and develop the market for inhalation drugs. Many drug developers…

Stort reportage i Sydsvenskan

Stort reportage om Iconovo i Sydsvenskan Sydsvenskan som är Södra Sveriges ledande morgontidning, ägnar två helsidor åt Lundabolaget…

Improved performance with inhalation

When you think of inhaled medicine, you often think of treatments for asthma, COPD and other conditions in the lungs and airways. Today,…

Replacing injections with inhalation

There are many therapies given as injections, that are temperature sensitive and challenging to store and transport, for example insulin…

Inhalation made easy with ICOone

There is a growing interest in delivering drugs by inhalation, not only medicines that treat the lungs and airways – such as those against…